Leave a reply →
We are delighted to announce that the results of the clinical phase II study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published in the journal Nature Communications (2017 impact factor: 12.353)
We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes.
The full citation is: Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat Commun. 2018 Sep 18;9(1):3789